All lobbying filings

RK STRATEGIES, INC.

Lobbying for RECCE PHARMACEUTICALS LTD · Pharmaceutical Company - Anti-infectives

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $20,000.00 income · posted Jul 18, 2026

Official filing document

Lobbying activity 3

Health Issues

General healthcare/wound care issues Pandemic and All Hazards Preparedness Act Reauthorization Appropriations Issues

Defense

General biodefense/wound care issues Pandemic and All Hazards Preparedness Act Reauthorization Other Appropriations Issues Related to Wound Care/Biodefense

Veterans

General wound care issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.